96
Duality Biotherapeutics, Inc.
9606.HK · HKSE
$184.00 -1.39% (-$2.60)
1M -4.36%
Market Cap ¥14.5B
P/E Ratio -
Div. Yield -
ROE 74.20%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 9.98x
P/S 17.19x
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 940.78%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 170.82%
Op. margin 185.34%
FCF margin 48.02%
Quality
3 /100
Poor ROE 74.20%
ROA 41.02%
Asset turnover 0.24x
Debt
100 /100
Low Current ratio 1.99x
Debt/Equity 0.26x
Net debt/EBITDA N/A
Stability
11 /100
Unstable Rev. volatility 64,408.02%
EPS volatility 120.25%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 9606.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zhongyuan Zhu
Employees
231
Headquarters
Shanghai